Correction for age of anticardiolipin antibodies cut-off points

Journal of Clinical Laboratory Analysis

Volumn 14, Issue 3, 2000, Pages 87-90

  Rapizzi, Elena ^a   Ruffatti, Amelia ^a,b   Tonello, Marta ^a   Piccoli, Antonio ^a   Calligaro, Antonia ^a   Sfriso, Paolo ^a   Todesco, Silvano ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Cattedra e Divisione di Reumatologia   (Italy)

Author keywords

Adult anticardiolipin antibodies; Anticardiolipin antibodies; Antiphospholipid antibodies; Elderly anticardiolipin antibodies; ELISA; Pediatric anticardiolipin antibodies

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; AGE; AGED; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; STANDARDIZATION;

ADOLESCENT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; MALE; MIDDLE AGED; REFERENCE VALUES; SEROLOGIC TESTS;

EID: 0034100775     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(2000)14:3<87::AID-JCLA1>3.0.CO;2-O     Document Type: Article

References (20)

1. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990;112:682-698.
2. Asherson RA, Block S, Houssiau FA, Hughes GRV. Systemic lupus erythematosus and lymphoma: association with antiphospholipid syndrome. J Rheumatol 1991;18:277-279.
3. Stiehm ER, Fulginiti VA. Immunologic disorders in infants and children. Philadelphia, London, Toronto: WB Saunders Company; 1980. 227 p.
4. Buckley CE, Buckley EG, Dorsey FC. Longitudinal changes in serum immunoglobulin levels in other humans. Fed Proc 1974;33:2036-2039.
5. Radl J, Sepers JM, Skvaril F, Morell A, Hijmans W. Immunoglobulins patterns of humans over 95 years of age. Clin Exp Immunol 1975; 22:84-90.
6. Manoussakis MN, Tzioufas AG, Silis MP, Pange PJ, Goudevenos J, Moutsopoulos HM. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987;69:557-565.
7. Ruffatti A, Rossi L, Calligaro A, Del Ross T, Lagni M, Marson P, Todesco S. Autoantibodies of systemic rheumatic diseases in the healthy elderly. Gerontology 1990;36:104-111.
8. Ligthart GJ, Corberand JX, Fournier C, et al. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Aging Dev 1984;28:47-55.
9. Solinger AM. Drug-related lupus. Clinical and etiologic considerations. Rheum Dis Clin North Am 1988;14:187-202.
10. Harris EN. Antiphospholipid antibodies (Annotation). Brit J Haematol 1990;74:1-9.
11. Vaarala O, Palosuo T, Kleemola M, Aho K. Anticardiolipin response in acute infections. Clin Immunol Immunopathol 1986;41(1):8-15.
12. Barrile A, Quattrocchi P, Bonanno D, et al. Presence and significance of anticardiolipin antibodies in infactious diseases. Recenti Prog Med 1992;83(6):350-353.
13. Kanariou M, Petridou E, Liatsis M, Revinthi K, Mandalenaki-Lambrou K, Trichopoulos D. Age patterns of immunoglobulins G, A and M in healthy children and the influence of breast feeding and vaccination status. Pediatr Allergy Immunol 1995;6(1):24-29.
14. Ruffatti A, Calligaro A, Del Ross T, et al. Anti-double-stranded DNA antibodies in the healthy elderly: prevalence and characteristics. J Clin Immunol 1900;10:300-303.
15. Derkesen RHWM. Clinical manifestation and management of the antiphospholipid syndrome. Lupus 1996;5:167-169.
16. Ruffatti A, De Silvestro G, Ghirardello A, et al. A Catastrophic antiphosphilid syndrome: the importance of high levels of warfarin anticoagulation. J Intern Med 1994;235:81-83.
17. Berstein ML, Salusinsky-Sternbach M, Bellefleur M, Esseltine DW. Thrombotic and hemorragic complications in children with the lupus anticoagulant. Am J Dis Child 1984;138:1132-1135.
18. Guariso G, Ruffatti A, Casonato A, Drigo P, Ghirardello A, Zancan L. Antiphospholipid syndrome in a child with trisomy 21: the relationship between anti-cardiolipin G antibodies and the von Willebrand factor. Clin Exp Rheumatol 1992;10:613-616.
19. The Antiphospholipid Antibodies in Stroke Study Group. Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. Stroke 1990;21:1268-1273.
20. Brey RL. Stroke prevention in patients with antiphospholipid antibodies. Lupus 1994;3:299-302.